Posted On: 12/20/2014 4:48:20 PM
Post# of 30066
Intriguing possibilities Belle Ozarks on YMB
rube PR release just two weeks ago...
"...and will be available before the end of 2014 for Investigational Use Only to assist the biopharmaceutical industry in its therapeutic Alzheimer's development programs."
GC et al will be PUNISHED if they dont launch next week or the week thereafter...if they do launch next week, the trading is typically thin, so pps climb could be breath-taking....
why convert E series at 8c instead of LPC? (because lpc will purchase shares upto 50c)
5M from E series dilution so far is only HALF of what the cost is correct?? thus...they must be planning on funds coming from elsewhere...so my thought is...they might have the half already secured via partnership spinoff of lympro upfront payment or pre-existing sales since the ESS-w closing date is Jan 31st.
comments/rebuttals warmly welcomed AMBS community.
rube PR release just two weeks ago...
"...and will be available before the end of 2014 for Investigational Use Only to assist the biopharmaceutical industry in its therapeutic Alzheimer's development programs."
GC et al will be PUNISHED if they dont launch next week or the week thereafter...if they do launch next week, the trading is typically thin, so pps climb could be breath-taking....
why convert E series at 8c instead of LPC? (because lpc will purchase shares upto 50c)
5M from E series dilution so far is only HALF of what the cost is correct?? thus...they must be planning on funds coming from elsewhere...so my thought is...they might have the half already secured via partnership spinoff of lympro upfront payment or pre-existing sales since the ESS-w closing date is Jan 31st.
comments/rebuttals warmly welcomed AMBS community.
(0)
(0)
